ArticleCellular and molecular life sciences : CMLS2025
RAB23 facilitates clathrin-coated nascent vesicle formation at the plasma membrane and modulates cell signaling.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
RAB23 is known to regulate signaling by several growth factors during organogenesis. RABs and other small GTPases function as molecular switches during cellular membrane trafficking. However, what has not been established is how RAB23 functions during cellular membrane trafficking and how this influences cell signaling. To address this, we characterized RAB23's localization in the endocytic pathway and determined the route of endocytosis. We find that RAB23 interacts with β-adaptin (AP2β1) subunit of the clathrin adaptor protein 2 (AP-2) complex, suggesting RAB23's involvement in clathrin-dependent endocytosis at the plasma membrane. Our results show that RAB23 might function at multiple steps during clathrin-coated nascent vesicle formation. We find that RAB23 interacts with clathrin assembly protein PICALM, vesicle curvature protein endophilin A2, and a protein linked with vesicle scission, cortactin. To understand the functionality of RAB23, we performed time-lapse live cell imaging of transferrin uptake, which showed that clathrin-dependent endocytosis is affected in RAB23 deficient osteoprogenitors with inefficient cargo internalization. We normalized transferrin uptake in RAB23 knockdown human osteosarcoma cells (MG-63) by overexpressing RAB23. Our results show that deficiency of RAB23 reduced the interaction between β-adaptin and clathrin. We demonstrate that vesicle formation upon BMP stimulation and subsequent signal transduction is aberrant in RAB23-deficient cells. We further show evidence by providing microarray data-driven hypergeometric test of differentially expressed genes in WT and RAB23-deficient samples which suggests RAB23's participation in vesicle formation, endocytosis and cell signaling. Collectively, our data indicate a role for RAB23 in vesicle formation, membrane trafficking, and cell signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.